Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2CNS 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 17Fallopian Tube Neoplasms 6Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Sarcoma 2Recurrence 2Pancreatic Neoplasms 2Melanoma 2Carcinoma, Non-Small-Cell Lung 2Uterine Diseases 1Uterine Cervical Diseases 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Recurrent Uterine Corpus Sarcoma 1Prostatic Neoplasms 1Hypertension 1Glioblastoma 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Cisplatin 3pembrolizumab 2amminedichloro(2-methylpyridine)platinum(II) 2Nivolumab 2Cytoreduction Surgical Procedures 2trastuzumab deruxtecan 1trametinib 1sodium thiosulfate 1pertuzumab 1pazopanib 1osimertinib 1motexafin gadolinium 1fludarabine 1danvatirsen 1dabrafenib 1cobimetinib 1cemiplimab 1alectinib 1aldesleukin 1X-Rays 1Ritonavir 1Remote Patient Monitoring 1Patient-Specific Modeling 1Pafolacianine 1Oxaliplatin 1Observation 1Mitomycin 1Microscopy, Electron 1Itraconazole 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × pazopanib × Gynecologic × Clear all
NCT01392352 2020-02-13

HYPAZ

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Terminated
31 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡